Compare HXHX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HXHX | ASBP |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 18.9M |
| IPO Year | 2025 | N/A |
| Metric | HXHX | ASBP |
|---|---|---|
| Price | $0.53 | $0.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 375.5K | ★ 67.6M |
| Earning Date | 04-30-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $25,571,810.00 | $1,941.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.01 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.48 | $0.09 |
| 52 Week High | $6.29 | $15.80 |
| Indicator | HXHX | ASBP |
|---|---|---|
| Relative Strength Index (RSI) | 36.39 | 29.17 |
| Support Level | $0.49 | $0.10 |
| Resistance Level | $0.64 | $0.11 |
| Average True Range (ATR) | 0.10 | 0.02 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 10.67 | 19.29 |
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.